# Media Relations Guidelines

**Document Version**: 1.0
**Last Updated**: November 9, 2025
**Owner**: Communications Manager & Executive Director
**Purpose**: Comprehensive framework for managing media relationships, press inquiries, and public communicationsâ€”ensuring consistent messaging, protecting Foundation reputation, and maximizing positive media coverage for AATD awareness.

---

## ðŸ“‹ Table of Contents

1. [Media Relations Philosophy](#media-relations-philosophy)
2. [Media Landscape & Target Outlets](#media-landscape--target-outlets)
3. [Spokesperson Designation & Training](#spokesperson-designation--training)
4. [Press Release Development](#press-release-development)
5. [Media Inquiry Response Procedures](#media-inquiry-response-procedures)
6. [Interview Preparation & Best Practices](#interview-preparation--best-practices)
7. [Message Development & Talking Points](#message-development--talking-points)
8. [Media Pitching Strategies](#media-pitching-strategies)
9. [Press Kit Contents & Distribution](#press-kit-contents--distribution)
10. [Embargo Policies for Research Announcements](#embargo-policies-for-research-announcements)
11. [Fact-Checking & Accuracy Procedures](#fact-checking--accuracy-procedures)
12. [Media Monitoring & Measurement](#media-monitoring--measurement)
13. [Post-Interview Follow-Up](#post-interview-follow-up)
14. [Correction & Clarification Procedures](#correction--clarification-procedures)
15. [Crisis Communication Protocols](#crisis-communication-protocols)
16. [Budget & Resources](#budget--resources)

---

## Media Relations Philosophy

### Foundation's Media Strategy

**Mission**: Leverage media to raise AATD awareness, educate public and healthcare providers, advocate for patients, and position Foundation as authoritative voice.

**Core Principles**:

**1. Proactive & Responsive**
- Don't wait for media to find usâ€”pitch stories, build relationships, offer expert commentary
- When media calls, respond quickly (within 2 hours during business hours)

**2. Patient-Centered Storytelling**
- Every media opportunity should advance patient interests (awareness, diagnosis, treatment access, research)
- Humanize AATD with patient stories (with consent)â€”statistics inform, stories inspire

**3. Science-Based Accuracy**
- All medical/scientific claims verified by Medical Advisory Board
- Never overstate research findings or promise cures
- Correct misinformation immediately (even if embarrassing)

**4. Transparency & Authenticity**
- Honest about challenges (diagnostic gaps, treatment costs, unmet needs)
- Don't dodge hard questionsâ€”address with empathy and facts
- Disclose Foundation funding sources when relevant

**5. Strategic Opportunism**
- Tie AATD awareness to news cycles (rare disease day, lung health month, genetic testing breakthroughs)
- Monitor for earned media opportunities (celebrity diagnosis, FDA approvals, research publications)

---

### Media Relations vs. Crisis Communications

**Media Relations** (This Document):
- Proactive storytelling, relationship building, positive coverage
- Goal: Increase AATD awareness, establish Foundation credibility

**Crisis Communications** (See Document 19: Crisis Management Plan):
- Reactive damage control, reputation protection
- Goal: Minimize harm, restore trust, correct misinformation
- **Key Difference**: Crisis = Board-level oversight, holding statements, legal counsel; Media Relations = day-to-day operations

**Crossover**: Media training prepares spokespersons for both routine interviews AND crisis scenarios.

---

## Media Landscape & Target Outlets

### Priority Media Tiers

**Tier 1: Health/Medical Outlets** (Primary Targetâ€”Direct Audience)
- **Medical Journals**: *JAMA*, *New England Journal of Medicine*, *CHEST*, *American Journal of Respiratory and Critical Care Medicine* (AJRCCM)
  - **Why**: Reach physicians who diagnose AATD
  - **Content**: Research findings, clinical guidelines, diagnostic algorithms
- **Health News Sites**: WebMD, Healthline, MedPage Today, Medscape
  - **Why**: Patients search AATD symptoms online
  - **Content**: Disease education, symptom recognition, patient stories
- **Medical Trade Publications**: *Pulmonology Advisor*, *Respiratory Therapy*, *Clinical Advisor*
  - **Why**: Respiratory therapists, nurse practitioners, physician assistants
  - **Content**: Clinical pearls, case studies, continuing education

---

**Tier 2: Mainstream Media** (Secondary Targetâ€”General Awareness)
- **National Newspapers**: *New York Times*, *Washington Post*, *USA Today*, *Wall Street Journal*
  - **Why**: Policy influence, public awareness, donor cultivation
  - **Content**: Human interest stories (patient journeys), policy/advocacy (FDA approvals, insurance coverage)
- **Network TV**: NBC Nightly News, ABC World News, CBS Evening News
  - **Why**: Reach 5-10 million viewers
  - **Content**: Feature segments (rare disease awareness, genetic testing importance)
- **Cable News Health Segments**: CNN Health, MSNBC Live, Fox News Health
  - **Why**: Expert commentary opportunities
  - **Content**: 3-5 minute interviews (ED or Medical Advisory Board member)
- **NPR**: *All Things Considered*, *Morning Edition*, *Fresh Air*
  - **Why**: Educated, engaged audience (likely donors)
  - **Content**: In-depth features (10-15 minutes)

---

**Tier 3: Regional/Local Media** (Tertiary Targetâ€”Community Engagement)
- **Local Newspapers**: City dailies, community weeklies
  - **Why**: Support group awareness, local fundraising events
  - **Content**: Event coverage (walks, galas), local patient profiles
- **Local TV News**: Morning shows, evening news health segments
  - **Why**: Visual storytelling (patient stories, support group footage)
  - **Content**: 2-3 minute feature stories
- **Podcast & Radio**: Health podcasts, AM/FM radio health shows
  - **Why**: Growing audience (50+ million podcast listeners)
  - **Content**: 20-30 minute interviews (conversational, educational)

---

**Tier 4: Specialty Outlets** (Niche Targetâ€”Specific Audiences)
- **Rare Disease Media**: *Rare Disease Report*, NORD blog, Global Genes
  - **Why**: Rare disease community, cross-pollination with other patient groups
  - **Content**: Advocacy strategies, research collaborations
- **Genetic Testing Industry**: *GenomeWeb*, *Precision Medicine*
  - **Why**: Laboratory professionals, genetic counselors
  - **Content**: Testing guidelines, reimbursement policies
- **Pharmaceutical Trade**: *FiercePharma*, *BioSpace*, *Endpoints News*
  - **Why**: Industry partnerships, clinical trial recruitment
  - **Content**: Drug development, patient perspectives on therapies

---

### Media Contact Database

**Build & Maintain** (CRM or Media Database Software):
- **Reporter Name**: Jane Smith
- **Outlet**: *Washington Post* Health Section
- **Beat**: Rare diseases, genetic conditions
- **Contact**: jane.smith@washpost.com, @janesmith (Twitter/X)
- **Past Coverage**: Wrote 3 AATD articles (2019, 2021, 2024)
- **Relationship**: Met at NORD conference 2023, responsive to pitches
- **Notes**: Prefers patient stories over research abstracts, 2-week lead time

**Database Size**: Start with 50-100 contacts (Year 1), grow to 500+ (Year 5).

---

## Spokesperson Designation & Training

### Official Spokespersons

**Primary Spokesperson**: Executive Director
- **Topics**: All Foundation matters (mission, programs, advocacy, fundraising)
- **Media Types**: All (print, TV, radio, podcast)
- **Availability**: 24/7 for crisis, business hours for routine

**Secondary Spokespersons**:
- **Chief Medical Officer or Medical Advisory Board Chair**: Clinical/scientific topics (research, treatment, diagnosis)
- **Patient Advocate or Board Member with AATD**: Patient perspective, lived experience
- **Development Director**: Fundraising events, donor stories (non-financial specifics)

**Backup Protocol**: If primary unavailable, Communications Manager contacts secondary in order of priority.

---

### Media Training

**Annual Media Training** (All Spokespersons):
- **Provider**: PR firm or media training consultant ($2,000-$5,000/day)
- **Format**: Half-day workshop (4 hours)
- **Components**:
  1. **Message Development** (1 hour): Craft 3 key messages, practice "bridging" (redirecting questions to key messages)
  2. **Mock Interviews** (2 hours): On-camera practice (print, TV, adversarial), video playback analysis
  3. **Crisis Scenarios** (1 hour): Hostile questions, "gotcha" moments, how to avoid traps

**Example Mock Interview Questions**:
- âœ… **Routine**: "What is AATD and why should people get tested?"
- âš ï¸ **Tough**: "Your Form 990 shows your ED earns $150Kâ€”isn't that excessive for a small nonprofit?"
- ðŸ”´ **Crisis**: "A patient claims your support group gave medical advice that led to harmâ€”your response?"

---

**Media Training Outcomes** (Measurable):
- Spokesperson can deliver 3 key messages within 60 seconds (TV interview soundbite)
- Spokesperson avoids "no comment" (always offers context, even if limited info available)
- Spokesperson maintains composure under pressure (measured by video analysisâ€”no defensive body language)

---

## Press Release Development

### When to Issue Press Release

**Yes, Issue Press Release**:
- âœ… Major organizational milestone (new program launch, $1M fundraising milestone, staff hiring)
- âœ… Research findings (peer-reviewed publication, clinical trial resultsâ€”if Foundation-funded)
- âœ… Advocacy victory (policy change, FDA approval of new AATD therapy)
- âœ… Major partnership (pharmaceutical company, academic institution, patient organization)
- âœ… Annual awareness campaigns (Rare Disease Day, Alpha-1 Awareness Month)
- âœ… Events (gala, walk, patient conferenceâ€”1 week prior for event preview, day-of for recap)

**No, Don't Issue Press Release**:
- âŒ Minor operational updates (new website, staff promotions below C-suite)
- âŒ Internal milestones (Board meeting, committee formationâ€”unless newsworthy decision)
- âŒ Routine programs (monthly support groupâ€”not newsworthy unless first in new city)

**Rule of Thumb**: If it's not interesting to journalist covering AATD, don't issue. Better to send 6 high-quality releases/year than 24 low-quality.

---

### Press Release Template

**Headline** (8-12 words, action-oriented):
> Mark Egly Foundation Launches Nationwide AATD Patient Navigation Program

**Subheadline** (15-25 words, additional context):
> $500,000 grant from ABC Foundation enables free genetic counseling and care coordination for 500 patients across 10 states

**Dateline**:
> [CITY, STATE]â€”[DATE]â€”

**Lede Paragraph** (Who, What, When, Where, Whyâ€”most important info first):
> The Mark Egly Foundation, the nation's leading Alpha-1 Antitrypsin Deficiency (AATD) patient advocacy organization, today announced the launch of a nationwide patient navigation program providing free genetic counseling, diagnostic support, and care coordination to 500 AATD patients across 10 states. The program is funded by a $500,000 grant from the ABC Foundation and begins enrollment January 15, 2026.

**Body Paragraphs** (2-4 paragraphs, inverted pyramidâ€”most to least important):
- **Paragraph 2**: Program details (who qualifies, how to enroll, services provided)
- **Paragraph 3**: Quote from ED or patient (humanizes story)
- **Paragraph 4**: Impact/need (why this mattersâ€”75% undiagnosed, preventable complications)

**Boilerplate** (Standard org description, 50-75 words):
> **About Mark Egly Foundation**
> Founded in 2021, the Mark Egly Foundation is dedicated to improving the lives of individuals affected by Alpha-1 Antitrypsin Deficiency (AATD) through education, research, advocacy, and patient support. The Foundation funds cutting-edge research, provides diagnostic resources, advocates for policy change, and connects patients with care. Learn more at www.markegly.org.

**Media Contact**:
> **Media Contact:**
> Jane Doe
> Communications Manager
> Mark Egly Foundation
> jane.doe@markegly.org
> (555) 123-4567

---

### Press Release Distribution

**Timing**: Send 9:00-10:00 AM Eastern (peak journalist reading time), Tuesday-Thursday (avoid Monday/Friday).

**Distribution Channels**:
1. **Media Database** (Direct emails to 50-100 targeted journalists)
2. **Wire Service** (PR Newswire, Business Wireâ€”$400-$800/release, reaches 1,000+ outlets)
3. **Foundation Website** (Post to News/Media section)
4. **Social Media** (Share link on Twitter/X, Facebook, LinkedIn)
5. **Email Newsletter** (Include in donor/patient newsletter)

**Follow-Up**: 24-48 hours after distribution, Communications Manager follows up with top 10 priority journalists (phone or email: "Did you receive our release? Available for interview?").

---

## Media Inquiry Response Procedures

### Inquiry Intake Process

**All Media Inquiries Routed To**: Communications Manager (primary), Executive Director (backup)

**Contact Methods**:
- **Email**: media@markegly.org (monitored 8am-6pm ET)
- **Phone**: (555) 123-4567 (direct line, voicemail checked hourly)
- **Social Media DMs**: Twitter/X, LinkedIn (monitored twice daily)

**Response Timeline**:
- **Deadline-driven inquiries** (reporter needs response by 3pm today): Respond within 2 hours
- **Routine inquiries** (story in development, no immediate deadline): Respond within 24 hours
- **After-hours inquiries**: Check email/voicemail 8am next business day (unless crisisâ€”see Crisis Communication Plan)

---

### Inquiry Triage

**Questions to Ask Journalist**:
1. **Outlet**: "Which publication/station are you with?"
2. **Story Angle**: "What's the focus of your story?"
3. **Deadline**: "When do you need information by?"
4. **Format**: "Are you seeking written statement, phone interview, or on-camera interview?"
5. **Other Sources**: "Who else are you interviewing for this story?"

**Decision Tree**:
- **Positive/Neutral Story** (patient profile, awareness campaign) â†’ Facilitate interview, provide spokesperson
- **Investigative/Critical Story** (nonprofit financial questions, patient complaint) â†’ Consult ED + legal counsel before responding
- **Outside Expertise** (clinical question beyond Foundation's scope) â†’ Refer to Medical Advisory Board or external expert

---

### Sample Response Templates

**Positive Inquiry**:
> Hi [Reporter Name],
>
> Thank you for reaching out! We'd be happy to help with your story on AATD awareness. Our Executive Director, [Name], is available for a phone interview [Tuesday 2-4pm or Wednesday 10am-12pm]. Would either time work?
>
> I can also provide:
> - Patient stories (with consent)
> - AATD fact sheet
> - High-res photos
>
> Best,
> [Communications Manager]

**Investigative Inquiry** (Buy Time):
> Hi [Reporter Name],
>
> Thank you for your inquiry. We take [issue] seriously and want to provide accurate information. Let me research your questions and get back to you by [deadline]. Can you confirm your specific questions in writing?
>
> Best,
> [Communications Manager]

**Decline Interview** (Rare, But Sometimes Necessary):
> Hi [Reporter Name],
>
> Thank you for thinking of us. Unfortunately, [topic] is outside our organizational expertise. I'd recommend contacting [alternative sourceâ€”Medical Advisory Board member, NORD, pulmonary society].
>
> If your story touches on AATD patient advocacy, we're happy to help.
>
> Best,
> [Communications Manager]

---

## Interview Preparation & Best Practices

### Pre-Interview Checklist

**24 Hours Before Interview**:
- [ ] Confirm: Time, date, format (phone/video/in-person), duration
- [ ] Research journalist: Read past articles, understand their angle
- [ ] Develop talking points: 3 key messages, supporting facts, patient stories
- [ ] Anticipate questions: List 10 likely questions, draft answers
- [ ] Gather materials: AATD fact sheet, Foundation one-pager, patient photos (if applicable)
- [ ] Practice: Rehearse talking points aloud, time responses (30-60 seconds each)

---

### Interview Best Practices

**The 3 Cs**:
1. **Clear**: Use plain language (no jargonâ€”say "genetic lung disease," not "serine protease inhibitor deficiency")
2. **Concise**: 30-60 second answers (reporters edit long responses, you lose control)
3. **Compelling**: Lead with impact ("75% undiagnosed means 75,000 Americans living with preventable lung damage")

**Bridging Technique** (Redirect to Key Messages):
- **Reporter asks**: "How much does your ED earn?"
- **Bridge**: "Our ED's compensation is within industry standards for nonprofits our size, which is important because it allows us to attract top talent to serve AATD patients. Let me tell you about our impactâ€”last year we helped 200 patients get diagnosed..."
- **Key**: Acknowledge question â†’ Pivot to key message

**Avoid**:
- âŒ "No comment" (sounds guiltyâ€”instead: "I don't have that information now, but I'll follow up")
- âŒ "Off the record" (nothing is truly off-recordâ€”assume everything is quotable)
- âŒ Speculation ("I think," "Maybe," "Probably"â€”stick to facts)
- âŒ Negative language ("We're struggling," "We failed"â€”reframe: "We're growing to meet demand," "We learned valuable lessons")

---

### TV Interview Specifics

**Appearance**:
- **Wardrobe**: Solid colors (blue, gray, burgundyâ€”avoid white, black, patterns), professional but approachable
- **Grooming**: Minimal jewelry (avoid jangly bracelets), hair out of face, light makeup (prevents shine on camera)

**Body Language**:
- **Eye contact**: Look at interviewer, not camera (unless direct-to-camera shot)
- **Posture**: Sit forward slightly (engaged), hands visible (use gestures, but not excessive)
- **Smile**: Warm, but appropriate to topic (don't smile when discussing patient suffering)

**Technical**:
- **Microphone check**: Test audio before live segment
- **Background**: Ensure professional setting (Foundation office, bookshelfâ€”not busy cafÃ©)
- **Lighting**: Face light source, avoid backlighting (silhouette)

---

## Message Development & Talking Points

### Core Foundation Messages

**Message 1: AATD is Underdiagnosed & Serious**
> "Alpha-1 Antitrypsin Deficiency affects 1 in 2,500 Americansâ€”100,000 peopleâ€”but 75% don't know they have it. Without diagnosis, patients suffer preventable lung and liver damage. A simple blood test can identify AATD and open access to life-saving treatments."

**Message 2: Foundation Bridges Diagnostic Gap**
> "The Mark Egly Foundation connects patients with genetic testing, expert pulmonologists, and peer support. Last year, our patient navigation program helped 200 people get diagnosedâ€”200 lives changed by knowing their genetic status and accessing treatment."

**Message 3: Research & Advocacy Drive Progress**
> "We fund cutting-edge research ($500K in grants annually) and advocate for policy changes to improve AATD care. Our recent advocacy helped expand insurance coverage for genetic testing, benefiting thousands of patients nationwide."

**Usage**: Spokespersons memorize these messages, work into every interview (2-3 times per 10-minute interview).

---

### Issue-Specific Talking Points

**Topic: Genetic Testing**
- âœ… "Everyone with COPD or unexplained liver disease should be tested for AATDâ€”it's a simple blood test"
- âœ… "Genetic testing empowers patients with knowledge and connects them to targeted therapies"
- âœ… "We provide free genetic counseling to help patients understand results and implications for family members"

**Topic: Treatment Access**
- âœ… "Augmentation therapy can slow AATD lung decline, but insurance coverage is inconsistent"
- âœ… "Our patient assistance program helps navigate insurance denials and connects patients with financial aid"
- âœ… "Patients shouldn't have to choose between life-saving treatment and bankruptcy"

**Topic: Research Funding**
- âœ… "We fund researcher-initiated grants ($50K-$150K) focused on improving diagnosis, treatment, and quality of life"
- âœ… "Our research priorities are set by patientsâ€”we ask what matters most to their daily lives"
- âœ… "Every research dollar invested today means better outcomes for patients tomorrow"

---

## Media Pitching Strategies

### Pitch Development

**Pitch = 3 Sentences**:
1. **Hook**: Why this story matters now (news peg, timely angle)
2. **Story**: What makes it compelling (patient journey, data, visual elements)
3. **Ask**: What you're offering (exclusive interview, access to patient, expert commentary)

**Example Pitch** (Email to Health Reporter):
> **Subject: Story Ideaâ€”Rare Genetic Disease Hides in Plain Sight (75% Undiagnosed)**
>
> Hi [Reporter Name],
>
> With Rare Disease Day approaching (Feb 28), I wanted to pitch a story on Alpha-1 Antitrypsin Deficiency (AATD)â€”a genetic lung/liver disease affecting 100,000 Americans, yet 75% don't know they have it.
>
> I can connect you with Sarah, a 42-year-old mother of three who was misdiagnosed with asthma for 15 years before a simple genetic test revealed AATD. Her story illustrates why genetic testing mattersâ€”and how patients suffer when diagnosis is delayed.
>
> Would you be interested in a 10-minute call this week to discuss? I can also provide AATD fact sheets, patient photos, and expert interviews.
>
> Best,
> [Communications Manager]
> Mark Egly Foundation
> media@markegly.org | (555) 123-4567

---

### Pitch Timing & News Pegs

**Annual Awareness Days** (Plan 6-8 Weeks Ahead):
- **Rare Disease Day** (Feb 28): Pitch AATD as rare disease example
- **Alpha-1 Awareness Month** (Marchâ€”Foundation-designated): Media blitz
- **National Genetic Counseling Awareness Day** (Nov 8): Pitch genetic testing importance
- **Lung Health Month** (October): Pitch AATD as lung disease story

**Research Publication** (Coordinate with Journal Embargo):
- If Foundation-funded research published, pitch 2 weeks before embargo lifts (see Embargo Policies section)

**FDA Approval / Policy Change**:
- New AATD therapy approved â†’ Pitch within 24 hours (patient access angle)

**Seasonal Health Stories**:
- Winter: "Cold or COPD? When breathlessness signals genetic condition"
- Spring: "Allergy season alertâ€”AATD symptoms often mistaken for allergies"

---

## Press Kit Contents & Distribution

### Digital Press Kit (Website Media Page)

**Must-Have Components**:

**1. Foundation Fact Sheet** (1-2 pages, PDF):
- Mission, history, programs, impact stats (# patients served, # research grants awarded)
- Key staff bios (ED, Medical Advisory Board Chair)
- Contact info

**2. AATD Disease Fact Sheet** (2 pages, PDF):
- What is AATD? (definition, inheritance, prevalence)
- Symptoms (shortness of breath, liver disease, early-onset emphysema)
- Diagnosis (blood test, genetic testing)
- Treatment options (augmentation therapy, lung transplant)
- Patient resources (Foundation programs)

**3. High-Resolution Photos**:
- Foundation logo (PNG, 300 DPI)
- Executive Director headshot (professional, 300 DPI)
- Patient photos (diverse ages, genders, ethnicitiesâ€”with model releases)
- Support group photos (meetings, eventsâ€”faces visible, smiling)
- Infographics (AATD inheritance pattern, diagnostic journey)

**4. Media Contact Info**:
- Communications Manager (name, email, phone, photo)
- After-hours contact (ED cell phone for crisis)

**5. Recent Press Releases** (Archive past 12-24 months)

**6. Media Coverage** (Clips):
- Links to recent articles, TV segments (embedded videos)
- "As Seen In" logos (NPR, Washington Post, etc.)

---

### Physical Press Kit (For Events)

**Printed Folder** (Contains):
- Foundation one-pager (mission, programs, impact)
- AATD fact sheet
- Recent press release
- Business cards (Communications Manager, ED)
- USB drive (photos, fact sheets, logosâ€”all digital assets)

**When to Use**: Gala, patient conference, press events (reporters present, hand out kits).

---

## Embargo Policies for Research Announcements

### What is Embargo?

**Definition**: Agreement between journal/researcher and mediaâ€”reporters receive research findings early (for story preparation) but cannot publish until embargo lifts (typically journal publication date).

**Purpose**:
- Ensures accurate reporting (journalists have time to read full study, interview experts)
- Creates "news wave" (multiple outlets publish simultaneously â†’ bigger impact)

---

### Foundation's Embargo Policy

**If Foundation Funds Research Published in Peer-Reviewed Journal**:

1. **Coordinate with Journal**: Contact journal's press office 4 weeks before publication
   - Confirm embargo date/time (usually 12:01 AM ET on publication date)
   - Request advance copy of study (under embargo)

2. **Develop Press Materials** (2 weeks before embargo):
   - Press release (summarizes findings, quotes researchers + Foundation ED)
   - Patient perspective statement (how findings impact patients)
   - Lay summary (translates science into plain language)

3. **Embargo Distribution** (1 week before embargo):
   - Send press release + study to 50-100 journalists marked **"EMBARGOED UNTIL [DATE/TIME]"**
   - Offer researcher + ED interviews (under embargo)

4. **Embargo Lift** (Publication Day):
   - Post press release publicly (website, social media)
   - Pitch follow-up stories ("What This Means for AATD Patients" angles)

**Embargo Violation** = publishing before lift time â†’ journal/researchers blacklist violator, Foundation loses credibility. **Never break embargoes.**

---

## Fact-Checking & Accuracy Procedures

### Pre-Publication Review

**When Reporter Offers Fact-Check** (Common for print, less for TV):
- âœ… **Accept opportunity**: "Yes, please send relevant sectionsâ€”we want to ensure accuracy"
- âœ… **Review promptly**: 24-48 hour turnaround
- âœ… **Limit edits to factual errors**: Don't rewrite for tone or messaging (reporters resent heavy-handed edits)

**Example Corrections**:
- âœ… "Article states '1 in 5,000 Americans have AATD'â€”should be 1 in 2,500"
- âœ… "Quote attributes statement to EDâ€”should be Medical Advisory Board Chair"
- âŒ "Article describes program as 'struggling to gain traction'â€”please change to 'growing rapidly'" (This is editorial judgment, not factual error)

---

### Internal Fact-Check Process (Before Foundation Issues Statement)

**All Press Releases/Talking Points Reviewed By**:
1. **Communications Manager**: Grammar, messaging, clarity
2. **Executive Director**: Strategic alignment, accuracy of Foundation info
3. **Medical Advisory Board** (if clinical/scientific content): Verify disease facts, treatment claims
4. **Legal Counsel** (if sensitive): Review for defamation risk, privacy compliance

**Review Timeline**: Allow 3-5 business days for internal review before distributing press release.

---

## Media Monitoring & Measurement

### What to Monitor

**Daily Monitoring** (Automated Alerts):
- **Google Alerts**: Set alerts for "Alpha-1 Antitrypsin Deficiency," "AATD," "Mark Egly Foundation"
- **Social Media Monitoring**: Mention tracking on Twitter/X, Facebook, Instagram (Hootsuite, Sprout Social)
- **News Aggregators**: Google News, Feedly (RSS feeds for AATD keywords)

**Weekly Monitoring** (Manual Review):
- **Broadcast Monitoring**: TV News Archive (search transcripts for AATD mentions)
- **Podcast Monitoring**: Podcast search engines (Apple Podcasts, Spotifyâ€”search AATD)

---

### Media Measurement Metrics

**Quantitative Metrics**:
- **Impressions**: Total potential audience (e.g., NYT article reach = 10M daily readers)
- **Article Count**: # of articles/segments mentioning Foundation (goal: 50+/year by Year 5)
- **Share of Voice**: Foundation mentions vs. competitor organizations (track NORD, other rare disease orgs)
- **Advertising Equivalency** (AVE): Value if paid for coverage (e.g., full-page NYT ad = $150Kâ€”article = "earned $150K")

**Qualitative Metrics**:
- **Sentiment**: Positive, neutral, negative (track ratioâ€”goal: 90%+ positive/neutral)
- **Message Penetration**: Do articles include Foundation's 3 key messages? (track %)
- **Spokesperson Performance**: Was ED quoted accurately? On-message? (review each clip)

---

### Media Monitoring Tools

**Free Tools**:
- Google Alerts ($0)
- Social media platform search ($0)
- TV News Archive ($0â€”public access)

**Paid Tools** (Year 3+, Budget $2,000-$8,000/year):
- **Meltwater**: Media monitoring, sentiment analysis, competitor tracking ($3,000-$6,000/year)
- **Cision**: Media database + monitoring ($5,000-$10,000/year)
- **Critical Mention**: Broadcast monitoring (TV, radio) ($2,000-$4,000/year)

**ROI**: If monitoring identifies 1 major media opportunity (e.g., reporter seeking AATD expert, Foundation spokesperson featured on NBC Nightly News = 5M impressions), tool pays for itself.

---

## Post-Interview Follow-Up

### Immediate Follow-Up (Same Day)

**Thank-You Email**:
> Hi [Reporter Name],
>
> Thank you for the interview today! I enjoyed discussing AATD awareness with you.
>
> As promised, attached are:
> - AATD fact sheet
> - High-res photo of [patient/ED/event]
> - Contact info for follow-up questions
>
> If you need anything else, don't hesitate to reach out. Looking forward to seeing the story!
>
> Best,
> [Communications Manager]

---

### Post-Publication Follow-Up

**Once Article Published**:
1. **Share Coverage**: Post to Foundation social media, email newsletter
2. **Thank Reporter**: Email appreciation ("Great piece! Our patients found it helpful")
3. **Maintain Relationship**: Add to "friendly journalists" list (pitch future stories)
4. **Evaluate Performance**: Review articleâ€”were key messages included? Accurate? Tone positive?

**If Coverage Negative**:
- Review internally (ED + Communications Manager): Justified criticism or misinformation?
- If justified, address issues (improve programs, transparency)
- If misinformation, consider correction request (see next section)

---

## Correction & Clarification Procedures

### When to Request Correction

**Request Correction If**:
- âœ… Factual error (incorrect statistics, misattributed quotes, wrong program details)
- âœ… Misrepresentation causing harm (e.g., article says Foundation doesn't serve patients of colorâ€”factually untrue, damages reputation)

**Don't Request Correction If**:
- âŒ Unflattering but accurate portrayal (article notes ED salary is highâ€”factually correct per 990)
- âŒ Editorial judgment (reporter emphasizes challenges over successesâ€”their prerogative)

---

### Correction Request Process

**Step 1: Contact Reporter** (Not Editorâ€”Start at Source)
> Hi [Reporter Name],
>
> Thank you again for covering AATD awareness. I noticed one factual error in the article: it states "1 in 5,000 Americans have AATD," but the correct prevalence is 1 in 2,500.
>
> Would you be able to correct this? Accurate prevalence data is important for public awareness.
>
> Thank you,
> [Communications Manager]

**Step 2: If Reporter Unresponsive, Contact Editor**
> Hi [Editor Name],
>
> I reached out to [Reporter] about a factual error in [Article Title] but haven't heard back. The article states incorrect AATD prevalence (1 in 5,000 vs. correct 1 in 2,500).
>
> Could you issue a correction? We want to ensure accurate rare disease information.
>
> Thank you,
> [Communications Manager]

**Step 3: If Still Unresponsive, Consider**:
- Public response (social media thread correcting errorâ€”rare, only if error egregious)
- Legal counsel (defamation claimâ€”extremely rare, only if malicious falsehood causing financial harm)

**Most Outlets Will Correct**: Reputable media care about accuracyâ€”polite, factual requests usually honored.

---

## Crisis Communication Protocols

### When Media Relations Becomes Crisis

**Triggers** (Escalate to Crisis Mode):
- ðŸ”´ Investigative story targeting Foundation (fraud allegations, patient harm claims)
- ðŸ”´ Multiple negative articles in short timeframe (reputation attack)
- ðŸ”´ Viral social media crisis (angry patient/donor post goes viral)
- ðŸ”´ Legal issue with media implications (lawsuit filed, regulatory investigation)

**Immediate Actions**:
1. **Alert Executive Director + Board Chair** (within 1 hour)
2. **Consult Legal Counsel** (before responding)
3. **Activate Crisis Communication Plan** (Document 19â€”holding statements, spokesperson protocols)
4. **Monitor 24/7** (media mentions, social media)

**See Document 19: Crisis Management Plan for full protocols.**

---

### Holding Statements

**Use When**: Need to respond quickly but lack full information.

**Template**:
> "We are aware of [issue] and take it very seriously. We are reviewing the matter thoroughly and will provide more information as soon as possible. The Foundation's priority is always the wellbeing of AATD patients."

**Never**: "No comment" (implies guilt or evasion).

---

## Budget & Resources

### Year 1-2 Budget (Startup, <$100K Media Budget)

**Personnel**:
- **Communications Manager** (0.5-1.0 FTE): $35,000-$70,000
- **ED time** (10% for spokesperson duties): $12,000-$15,000

**Tools & Services**:
- **Media Database** (Cision, Meltwaterâ€”optional Year 1): $0 (use free Google/LinkedIn)
- **Press Release Distribution** (PR Newswireâ€”6 releases/year): $2,400-$4,800
- **Media Training** (one-time): $2,000-$5,000
- **Stock Photos** (iStock, Shutterstock): $500-$1,000

**Total Year 1-2 Budget**: **$52,000-$96,000/year**

---

### Year 3-5 Budget (Growth, $100K-$300K Media Budget)

**Personnel**:
- **Communications Manager** (1.0 FTE): $70,000-$85,000
- **Communications Associate** (0.5 FTE): $25,000-$35,000
- **ED + Spokespersons**: $15,000-$20,000 (time allocation)

**Tools & Services**:
- **Media Monitoring** (Meltwater, Cision): $3,000-$6,000/year
- **Press Release Distribution** (12 releases/year): $4,800-$9,600
- **Media Training** (annual refresh): $2,000-$5,000
- **Photography/Videography** (professional patient stories): $5,000-$10,000
- **Website Media Center** (design, hosting): $2,000-$5,000

**Total Year 3-5 Budget**: **$126,000-$175,000/year**

---

### Year 6-10 Budget (Mature, $300K-$500K Media Budget)

**Personnel**:
- **Director of Communications** (1.0 FTE): $90,000-$110,000
- **Media Relations Manager** (1.0 FTE): $65,000-$80,000
- **Digital Communications Specialist** (1.0 FTE): $55,000-$70,000

**Tools & Services**:
- **PR Firm** (retainer, optional): $5,000-$10,000/month ($60K-$120K/year)
- **Media Monitoring Suite** (Meltwater + Broadcast): $8,000-$12,000/year
- **Video Production** (patient documentary, PSAs): $20,000-$50,000
- **Conferences** (PRSA, PRSSA, health journalism): $5,000-$10,000

**Total Year 6-10 Budget**: **$303,000-$452,000/year**

---

### ROI Measurement

**Media Coverage Value**:
- 50 articles/year Ã— $50K average AVE = **$2.5M earned media value**
- If Communications budget = $150K, **ROI = 16:1** (every $1 spent = $16 earned media value)

**Non-Financial ROI**:
- Increased diagnostic rate (articles drive testing)
- Donor acquisition (media coverage attracts donors)
- Policy influence (media coverage supports advocacy)

---

## Conclusion

### Media Relations as Mission Multiplier

**Bottom Line**: Media coverage amplifies Foundation's impactâ€”one TV segment reaches 5 million people (vs. 5,000 on Foundation email list). Strategic media relations = cost-effective awareness and advocacy tool.

**Relationship Building**: Great media relations is 50% storytelling, 50% relationship cultivation. Invest in journalist relationships, respond promptly, be helpfulâ€”media will return when AATD stories arise.

**Continuous Learning**: Media landscape evolves (podcasts, social media, AI-generated content)â€”commit to ongoing education, adapt strategies, experiment with new formats.

---

### Implementation Checklist

**Year 1 Launch**:
- [ ] Hire Communications Manager (0.5-1.0 FTE)
- [ ] Develop 3 core messages + talking points
- [ ] Build media database (50-100 journalists)
- [ ] Media train ED + 2 secondary spokespersons
- [ ] Issue 6 press releases (major milestones)
- [ ] Secure 10-20 media placements (local + health outlets)

**Year 2-3 Scale**:
- [ ] Expand Communications Manager to 1.0 FTE
- [ ] Subscribe to media monitoring tool (Meltwater)
- [ ] Develop digital press kit (website media center)
- [ ] Issue 12 press releases/year
- [ ] Secure 30-50 media placements (add national outlets)
- [ ] Launch annual awareness campaign (Rare Disease Day, Alpha-1 Awareness Month)

**Year 4-5 Maturity**:
- [ ] Hire Communications Associate (0.5 FTE)
- [ ] Establish relationships with 10+ friendly journalists (regular contributors)
- [ ] Achieve 50+ media placements/year
- [ ] Secure national outlet feature (NPR, NYT, NBC Nightly News)
- [ ] Media training for 5+ spokespersons (expand spokesperson pool)

---

**Document Owner**: Communications Manager
**Review Frequency**: Annually (update media contacts, adjust strategies)
**Board Oversight**: Communications Committee (if established) reviews media strategy quarterly
**Cross-References**:
- Crisis Management Plan (Document 19â€”media crisis protocols)
- Social Media Policy (Document 27â€”social media integration with media outreach)
- Crisis Communication Plan (Document 28â€”stakeholder notification, holding statements)

---

**Last Updated**: November 9, 2025
**Next Review**: November 2026
